Back

Efficacy of diet with low glycemic index on coronary artery disease

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Nutrition and heart disease Nutrition, Malnutrition and Heart Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jamol Uzokov

Republican Specialized Scientific-Practical Medical Center Therapy and Medical Rehabilitation, Tashkent (Uzbekistan)

8 More presentations in this session

Presentation thumbnail
Investigating the diverse role of ultra-processed foods on cardiometabolic multimorbidity: Highlights from the ATTICA prospective study (2002-2022)
Miss E. Damigou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Cardioprotective potential of oleuropein, hydroxytyrosol, oleocanthal and their combination: unravelling complementary effects on acute myocardial infarction and metabolic syndrome.
Professor I. Andreadou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Influence of chronic dietary nitrate on downstream atherogenic metabolites and the enteral microbiome
Doctor D. Messiha (Essen, DE)
Abstract Slides Video
Presentation thumbnail
Mediterranean-type diet trajectories and 20-year cardiovascular disease incidence: the ATTICA study (2002-2022)
Miss E. Damigou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Association of a healthy plant-based heart-protective diet with reduced cardiovascular disease incidence and mortality: findings from the UK Biobank Study
Doctor T. Wang (Sydney, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Nutrition and heart disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The effect of a diet reduction in advanced glycation end products on metabolic markers in patients with chronic coronary artery disease and type 2 diabetes.
thumbnail
Congress Presentation
Prognostic impact of composite lipid indices in patients with acute coronary syndrome undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
Analysis of the use of incretins in patients with coronary artery disease with DM 2 with preserved ejection fraction.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources